Literature DB >> 15161003

Effects of oral squamous cell carcinoma-derived TGF-beta1 on CD26/DPPIV expression in T cells.

Takashi Uematsu1, Hitoshi Tanaka, Minoru Yamaoka, Kiyofumi Furusawa.   

Abstract

BACKGROUND: Enzymatic activity levels of serum CD26/dipeptidylpeptidase (DPP) IV in oral cancer patients are lower than those in healthy subjects. However, the mechanism for this decrease is not yet fully understood.
MATERIALS AND METHODS: The influence of malignant cell-derived cytokines on cell surface CD26/DPPIV expression in human T cells was analyzed using an oral squamous cell carcinoma (SCC) cell line, KB, and peripheral blood T cells.
RESULTS: Tumor growth factor (TGF)-beta1 in KB-conditioned medium (KBCM) down-regulated CD26/DPPIV expression in T cells, which was responsible for the decreased DPPIV activities in the cultured supernatant. Expression p27kip in T cells was maintained in addition to G1 arrest when cultured with KBCM but was abolished by inclusion of anti-TGF-beta1 antibody.
CONCLUSION: SCC-derived TGF-beta1 down-regulates CD26/DPPIV expression in T cells, resulting in decreased serum CD26/DPPIV activity in oral cancer patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15161003

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Potential of soluble CD26 as a serum marker for colorectal cancer detection.

Authors:  Oscar J Cordero; Monica Imbernon; Loretta De Chiara; Vicenta S Martinez-Zorzano; Daniel Ayude; Maria Paez de la Cadena; F Javier Rodriguez-Berrocal
Journal:  World J Clin Oncol       Date:  2011-06-10

2.  CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis.

Authors:  Oscar J Cordero; Rubén Varela-Calviño; Tania López-González; Cristina Calviño-Sampedro; Juan E Viñuela; Coral Mouriño; Íñigo Hernández-Rodríguez; Marina Rodríguez-López; Bruno Aspe de la Iglesia; José María Pego-Reigosa; José María Pego
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

3.  Postoperative serum levels of sCD26 for surveillance in colorectal cancer patients.

Authors:  Loretta De Chiara; Ana M Rodríguez-Piñeiro; Oscar J Cordero; Lidia Vázquez-Tuñas; Daniel Ayude; Francisco J Rodríguez-Berrocal; María Páez de la Cadena
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

Review 4.  CD26 and Asthma: a Comprehensive Review.

Authors:  Juan J Nieto-Fontarigo; Francisco J González-Barcala; Esther San José; Pilar Arias; Montserrat Nogueira; Francisco J Salgado
Journal:  Clin Rev Allergy Immunol       Date:  2019-04       Impact factor: 8.667

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.